CRC Research Update — November 03, 2026
Today's colorectal cancer research highlights
Curated CRC research, accessible, accurate, actionable
The CRC Digest
Tuesday, November 03, 2026
IMPORTANT: The CRC Digest curates and summarizes publicly available research for informational and educational purposes only. Nothing in this newsletter constitutes medical advice, diagnosis, or treatment recommendation. The information provided should not be used as a substitute for professional medical advice. Always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition or treatment. Content is generated with AI assistance and reviewed by the editorial team. We are not medical professionals. Individual results, treatments, and outcomes vary.
CRC Research Update
-
TRIAL DATA
Short-course immunotherapy drives deep responses in resectable colon cancerIn the phase 2 UNICORN trial, neoadjuvant botensilimab plus balstilimab achieved major pathological responses in 36% of pMMR and 100% of dMMR colon cancer patients, with no recurrences reported at data cutoff. (Targeted Oncology)
-
RESEARCH
Disease-free survival strongly correlates with long-term outcomes after liver resectionA pooled analysis of 855 patients from nine randomized trials found that disease-free survival is highly correlated with post-surgical overall survival (ρ = 0.73) in resected liver-limited metastatic colorectal cancer, with high-burden patients showing a trend toward long-term benefit from surgery. (ESMO Open)
-
TREATMENT
Local therapy use for metastatic CRC increased, with 5-year survival at 50% for liver metastasesA Norwegian population study of 20,210 metastatic colorectal cancer patients found that 21% received local therapy (surgery, stereotactic radiotherapy, or ablation), with 5-year overall survival of 50% for liver metastases, 62% for lung, and 5% for brain. (JCO Oncology Practice)
-
LIVING WITH CRC
Patient navigation techniques identified for overcoming colonoscopy barriersAnalysis of the Colonoscopy Outreach for Rural Communities trial identified eight navigation techniques that successfully resolved scheduling (88%), knowledge (98%), transportation (82%), and language (83%) barriers to primary screening colonoscopy. (Journal of Ambulatory Care Management)
Today's research spans neoadjuvant immunotherapy responses, surgical outcomes in metastatic disease, and practical advances in screening navigation and molecular profiling.
Get CRC research intelligence delivered weekly, free.
SubscribeCRC Digest
Not Medical Advice
The CRC Digest provides research summaries for informational and educational purposes only. This is not medical advice. Always consult your healthcare provider before making any decisions about your care.
Content is curated with AI assistance and reviewed by the editorial team.
Browse Past Issues · Read our full disclaimer · Manage subscription
Useful? Forward it to a colleague. Many of the topics named here have a live research dossier, trajectory and evidence, at Signal Bureau.
Got this from a colleague? Subscribe here. We only ever add readers who sign themselves up.
Evolution Accelerator, Inc. (dba Evolution Labs) · 3941 Park Dr., Suite 20341, El Dorado Hills, CA 95762
You are receiving this because you subscribed to CRC Digest (self-serve signup)
Unsubscribe: honored promptly, no login required. · Privacy policy · Manage or delete your data